Nausea, vomiting and quality of life in women with breast cancer receiving chemotherapy
The aim of this study was to assess the quality of life (QoL) of women with breast cancer during chemotherapy and to identify the incidence of nausea and vomiting during the treatment Data were assessed with the application of the instrument of the European Organization for Research and Treatment of...
Saved in:
Published in | Revista gaúcha de enfermagem Vol. 34; no. 3; p. 110 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | Portuguese |
Published |
Brazil
01.09.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The aim of this study was to assess the quality of life (QoL) of women with breast cancer during chemotherapy and to identify the incidence of nausea and vomiting during the treatment Data were assessed with the application of the instrument of the European Organization for Research and Treatment of Cancer, EORTC-QLQ-C30 Portuguese version and breast cancer module BR-23, which was applied before, in the middle and in the end of the treatment. The participants were 79 women, of which 93% had nausea and 87% had vomited at least once during the treatment. QoL showed a slight decrease during treatment. Cronbach's alpha for each application of the questionnaires was 0.890492, 0.936392 and 0.937639. The availability of treatment information and guidelines on the management of nausea and vomiting is crucial for the proper management of the toxicities of chemotherapy. |
---|---|
ISSN: | 0102-6933 |